Instem, a leading provider of IT solutions to the global early development healthcare market, has acquired Notocord.
The total consideration, to be satisfied in cash, will be up to €4.2m, net of any cash acquired adjusted for a normalised level of working capital. The acquisition is expected to be immediately earnings enhancing. The consideration comprises €2.0m on completion and up to a further €2.2m, which is payable contingent upon the achievement of certain targets, including the future financial performance of Notocord.
At 3:48pm: (LON:INS) Instem Plc share price was +1.5p at 259p